Concepedia

Paul Hawtin

PH

4

Publications

447

Citations

4

H-Index

2002

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Paul Hawtin is an author at AstraZeneca (United Kingdom) specializing in natural sciences, medicine, and structural biology.

Top concepts

MedicineNatural SciencesPharmacologyDrug DiscoveryChemical BiologyMolecular BiologyStructural BiologyDrug DesignBiochemistryPharmacotherapy

Publications per year

2002–2008

4

Publications

4

Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor

Siân Rowsell, Paul Hawtin, Claire A. Minshull et al. · Journal of Molecular Biology · 2002 · 255 citations

Crystal Structure, Human Mmp9, Medicine +9

Crystal Structures of Human ADAMTS-1 Reveal a Conserved Catalytic Domain and a Disintegrin-like Domain with a Fold Homologous to Cysteine-Rich Domains

S. Gerhardt, G. Hassall, Paul Hawtin et al. · Journal of Molecular Biology · 2007 · 94 citations

Protein Function, Protein Assembly, Protein Folding +9

Novel Prostaglandin D Synthase Inhibitors Generated by Fragment-Based Drug Design

M. Hohwy, Loredana Spadola, Britta Lundquist et al. · Journal of Medicinal Chemistry · 2008 · 63 citations · Full text

Pharmaceutical Science, Hit Identification, Fragment-based Drug Design +18

Utility of lab‐on‐a‐chip technology for high‐throughput nucleic acid and protein analysis

Paul Hawtin, Ian M. Hardern, Rainer Wittig et al. · Electrophoresis · 2005 · 35 citations

Rows per page

1–4 of 4